Posted by Michael Wonder on 18 Jan 2018
Draft report for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
18 January 2018 - The draft report for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis is available for public comment.
The Department is now inviting submissions from interested stakeholders addressing the draft report to the PBAC for this review.
This public consultation process will be open for two weeks.
